ENDRA Life Sciences (NDRA) Enterprise Value (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Enterprise Value for 6 consecutive years, with -$11.8 million as the latest value for Q3 2021.
- Quarterly Enterprise Value fell 210.9% to -$11.8 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$11.8 million through Sep 2021, down 210.9% year-over-year, with the annual reading at -$7.2 million for FY2020, 17.06% down from the prior year.
- Enterprise Value for Q3 2021 was -$11.8 million at ENDRA Life Sciences, up from -$14.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$133679.0 in Q1 2017, with the low at -$16.8 million in Q1 2021.
- Average Enterprise Value over 5 years is -$5.5 million, with a median of -$3.9 million recorded in 2019.
- The sharpest move saw Enterprise Value tumbled 9136.41% in 2017, then surged 90.87% in 2018.
- Over 5 years, Enterprise Value stood at -$5.6 million in 2017, then dropped by 15.52% to -$6.5 million in 2018, then grew by 4.59% to -$6.2 million in 2019, then dropped by 17.06% to -$7.2 million in 2020, then plummeted by 63.18% to -$11.8 million in 2021.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$11.8 million, -$14.0 million, and -$16.8 million for Q3 2021, Q2 2021, and Q1 2021 respectively.